LTI-01-2001 A Phase 2 randomized placebo controlled double blind dose ranging study evaluating LTI-01 in patients with infected non-draining pleural effusions

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Lung Therapeutics, Inc.

Contributors

Wahidi, Momen Mohammed Principal Investigator

Start/End

May 5, 2020 - April 30, 2023